The aim? To bring pharma companies, industry experts, and policy makers closer to each other so that they can work together for a better, healthier tomorrow. In a major development for India’s healthcare and pharmaceutical industry, the International Pharma Federation (IPF) has signed a Memorandum of Understanding (MoU) with the PHD Chamber of Commerce and Industry (PHDCCI).
The big event took place on July 30, 2025, at the PHD House in Chandigarh. One way or the other, this partnership aims at bringing the pharma companies, experts, and policy makers together to work for a better and healthier tomorrow.
Who Were the Key People?
From IPF (International Pharma Federation):
- Sh. Gulshan Rawat – President of IPF
- Mr. Neeraj Giri – General Secretary of IPF
From PHDCCI (PHD Chamber of Commerce and Industry):
- Sh. Supreet Singh – Convener, Regional Pharmaceutical, Health and Wellness Committee
- Ms. Bharti Sood – Regional Director, PHDCCI
Also present:
- Sh. Shubham Singh – Resident Officer, PHDCCI
- Ms. Punya Bhatia – Resident Executive, PHDCCI
Their joint presence speaks volumes about the seriousness and importance placed on this partnership.
Why Is This MoU So Important?
Signing an MoU is just symbolic and is not enough by itself. It is the starting point of a long-term relationship focusing on growth, innovation, and global recognition.
In the simplest terms, what this MoU intends to do is:
1. Good Manufacturing Practices (GMP)
Those are guidelines that ensure medicines are of good quality. Both IPF and PHDCCI will now work together to promote good manufacturing practices at every possible small or large pharma company so that safe and effective medicines are manufactured.
2. Sharing Knowledge and Research
Both organizations will look at enhancing their exchange of ideas, research papers, and important updates. This will help all stay abreast with any new technologies, sciences, and market needs.
3. Trade Awareness and Assistance in Export
Many small pharma industries want to export drugs but have no clue how to do so. This alliance shall guide them on international pharmaceutical federation laws, packaging standards, and how to export.
4. Collaborative Global Trade Visits
IPF and PHDCCI will also dispatch teams of pharmaceutical professionals to other countries to study and explore new business opportunities. That means Indian pharma may now tap new global markets and evolve into a stronger player.
5. Policy and Regulatory Support
These organizations will also support the government in formulating better pharmaceutical policies, thereby reducing unnecessary regulations and improving the entire system of running pharmaceutical businesses.
What Will Be the Benefits of India?
India’s pharmaceutical sector was already dubbed the “Pharmacy of the World,” particularly after the COVID-19 pandemic.
Now with this MoU, India can:
- Export more quality medicines to other countries
- Create more job options in the healthcare and pharma sectors
- Train people to understand national & international standards
- Promote innovation & R&D (Research & Development)
- Become a leader in wellness & pharma globally
Future Plans and Vision
This MoU is just the starting point. Many activities are already in process:
- Establishing joint working committees
- Organizing national and international expos for pharma and wellness products
- Helping Indian startups through funding and mentorship
- Promoting herbal, ayurvedic, and natural medicines in the global market
- Providing job-oriented training to youth in pharma
Words from the Leaders
Sh. Gulshan Rawat, President of IPF, said:
“This partnership is a game-changer. Together, we will build a strong foundation that supports innovation and global leadership for Indian pharma.”
Mr. Neeraj Giri, General Secretary, IPF, shared:
“Our goal is simple – to help every pharma company in India grow and become globally competitive.”
Ms. Bharti Sood, Regional Director, PHDCCI, added:
“We look forward to bringing in new ideas and international collaborations that can take India’s pharma sector to the next level.”
Glimpse of the Ceremony
The event was vibrant with energy and hope. The leaders on both sides shook hands, exchanged ideas, and pledged to collaborate for the larger growth of the Indian pharma industry.
Photographs were clicked, the MoU was signed with pride, and celebrations ensued to mark the powerful step forward.
Behind the Scenes:
The big team of both IPF and PHDCCI worked on this partnership day and night. From drafting the MoU to planning the event, and even figuring out whom to invite, every little detail was handled with utmost care.
This shows how collaboration and teamwork can lead to something big and impactful.
Conclusion: What This Means for You
If you’re a:
Pharma company – support will come to you towards improvement, expansion and export.
Student – opportunities will throw themselves your way to learn and grow in pharma.
Government body – guidance from experts will help in making better policies.
Investor – new areas of interest from the pharma world will be your targets for investment.
Health-conscious People – you’ll get access to better quality & safer medicines
The MoU signed on 30th July 2025 is not just an agreement. It is a vision for a healthier, stronger India, built through cooperation, education, and shared goals.
Issued by:
Team IPF – International Pharma Federation
Together with PHDCCI, they aim to bring a brighter future for every Indian who depends on medicines and wellness products.